氨溴索治疗哮喘性支气管炎的疗效及安全性分析  

Analysis of the efficacy and safety of ambroxol in the treatment of asthmatic bronchitis

作　　者：龚海峰 Gong Haifeng(The Affiliated Rehabilitation Hospital of Xiangnan College(Formerly 240 Hospital of Hunan Provincial Nuclear Industry),Hunan Chenzhou 423000)

机构地区：[1]湘南学院附属康复医院(原湖南省核工业240医院),湖南郴州423000

出　　处：《中国社区医师》2020年第13期50-50,52,共2页Chinese Community Doctors

摘　　要：目的:研究氨溴索治疗哮喘性支气管炎的疗效和安全性。方法:2017年10月-2018年12月收治哮喘性支气管炎患者70例,随机分为两组,各35例。对照组采取常规治疗;观察组在常规治疗基础上使用氨溴索进行辅助治疗。比较两组治疗效果。结果:观察组咳嗽消失时间、肺哮鸣音消失时间、湿啰音消失时间及喘息消失时间均短于对照组,差异有统计学意义(P<0.05);观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论:使用氨溴索治疗哮喘性支气管炎能够取得更好的治疗效果。Objective:To study the stability and safety of ambroxol in the treatment of asthmatic bronchitis.Methods:From October 2017 to December 2018,70 patients with asthmatic bronchitis were enrolled,they were randomly divided into two groups with 35 cases in each group.The control group was treated with conventional therapy.The observation group was treated with ambroxol on the basis of conventional therapy.The therapeutic effects between the two groups were compared.Results:The cough disappearance time,the lung wheezing disappearance time,the wet rales disappearance time and the wheezing disappearance time in the observation group were shorter than in the control group,the differences were statistically significant(P<0.05).The total effective rate of treatment in the observation group was higher than in the control group,the difference was statistically significant(P<0.05).Conclusion:The use of ambroxol in the treatment of asthmatic bronchitis can achieve better results.

关 键 词：喘息性支气管炎 氨溴索 疗效及安全性 观察评价 

分 类 号：R562.21[医药卫生—呼吸系统]